Equity Overview
Price & Market Data
Price: $37.50
Daily Change: +$0.47 / 1.25%
Range: $36.84 - $37.51
Market Cap: $75,947,999,232
Volume: 4,893,945
Performance Metrics
1 Week: 6.02%
1 Month: -2.80%
3 Months: 10.13%
6 Months: -1.73%
1 Year: -7.61%
YTD: 10.88%
Company Details
Employees: 68629
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United Kingdom
Details
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, infectious, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, inflammation, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop vaccines for influenza and COVID-19, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.